文献速递主动脉外科

亚急性与慢性B型主动脉夹层TEVAR干预时机对主动脉重塑的影响

Optimal timing of thoracic endovascular aortic repair for subacute and chronic type B aortic dissection: insights from the Tokushukai Medical Database†.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

基于Tokushukai医学数据库110例发病至少2周后行TEVAR的B型主动脉夹层患者,评估干预时机对1年完全胸主动脉重塑(CTR)的影响。1年CTR率为67.3%,≤3个月组为88.4%,3-12个月组为57.1%,≥12个月组为18.5%。ROC曲线确认3个月为达成CTR的截断值,多变量分析显示发病至TEVAR间隔>3个月和初始胸段假腔直径是CTR失败的独立预测因素。

要点

  • 发病3个月内行TEVAR者1年CTR率达88.4%,显著高于延迟干预者
  • 发病至TEVAR间隔>3个月是CTR失败的独立预测因素(OR 9.75)
  • 初始胸段假腔直径增大亦预测CTR失败(OR 1.13)

核心结论

  • 发病3个月内早期行TEVAR对B型主动脉夹层实现完全主动脉重塑至关重要,建议符合条件的患者早期预防性TEVAR以优化结局。

研究设计与样本

  • 回顾性队列研究,纳入Tokushukai医学数据库中110例发病至少2周后行TEVAR的B型主动脉夹层患者。
  • 主要结局为1年时完全胸主动脉重塑(CTR),定义为胸段假腔血栓形成且假腔直径<10 mm至Th10水平。

主要发现

  • 1年CTR率为67.3%。
  • CTR率随干预时机延迟而降低:≤3个月组88.4%(n=69),3-12个月组57.1%(n=14),≥12个月组18.5%(n=27)。
  • ROC曲线分析确认3个月为达成CTR的截断值(AUC 0.857)。
  • 多变量分析显示发病至TEVAR间隔>3个月(OR 9.75,95%CI 2.86-33.28)和初始胸段假腔直径(OR 1.13,95%CI 1.02-1.27)是CTR失败的独立预测因素。
  • DeBakey IIIb亚组呈现相似趋势:3个月截断值,间隔>3个月OR 16.38(95%CI 3.54-75.83),初始胸段假腔直径OR 1.25(95%CI 1.00-1.54),初始腹主动脉直径OR 1.14(95%CI 1.01-1.29)预测CTR失败。

临床怎么用

  • 对符合条件的B型主动脉夹层患者,应考虑在发病3个月内行TEVAR以最大化完全主动脉重塑机会。
  • 初始胸段假腔直径较大的患者CTR失败风险更高,干预决策时需综合评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to evaluate the impact of intervention timing on thoracic aortic remodelling following thoracic endovascular aortic repair (TEVAR) for subacute and chronic type B aortic dissection (TBAD). METHODS: The study included 110 patients undergoing TEVAR for TBAD at least 2 weeks after onset, sourced from the Tokushukai Medical Database. The primary outcome was complete thoracic aortic remodelling (CTR) at 1 year, defined as thoracic false lumen thrombosis and a false lumen diameter <10 mm up to the level of Th10. RESULTS: The 1-year CTR rate was 67.3%. CTR was strongly associated with intervention timing: 88.4% (≤3 months: n = 69), 57.1% (3-12 months: n = 14) and 18.5% (≥12 months: n = 27). Receiver operating characteristic (ROC) curve analysis confirmed a 3-month cutoff for achieving CTR (area under the curve 0.857). Multivariable analysis identified interval from onset to TEVAR >3 months (odds ratio [OR] 9.75, 95% confidence interval [CI] 2.86-33.28) and initial thoracic false lumen diameter (OR 1.13, 95% CI 1.02-1.27) as independent predictors of CTR failure. Similar trends were observed in the DeBakey IIIb subgroup, with a 3-month cutoff for achieving CTR and interval from onset to TEVAR >3 months (OR 16.38, 95% CI 3.54-75.83), initial thoracic false lumen diameter (OR 1.25, 95% CI 1.00-1.54) and initial abdominal aortic diameters (OR 1.14, 95% CI 1.01-1.29) predicting CTR failure. CONCLUSIONS: Early TEVAR within 3 months of onset is crucial for achieving complete aortic remodelling in TBAD. Therefore, early preventive TEVAR in eligible patients is recommended to optimize outcomes.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Ueki C, Uchida N, Ohashi T, et al. Optimal timing of thoracic endovascular aortic repair for subacute and chronic type B aortic dissection: insights from the Tokushukai Medical Database†. Eur J Cardiothorac Surg. 2025. PMID: 39960881. doi:10.1093/ejcts/ezaf051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。